ANO5 gene replacement therapy (Cure Rare Disease/LGMD2L Foundation)
N/A
Report date: 2026/05/20 20:02:01
Base Information
Drug NameANO5 gene replacement therapy (Cure Rare Disease/LGMD2L Foundation)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCure Rare Disease
China Registration ClassN/A
Develop Information
Active CompaniesLGMD2L FoundationCure Rare Disease
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A